There is no question that effective & safe vaccines will offer the best solution for preventing GBS. We are at a really exciting point in vaccine development with several GBS vaccines now in trials involving pregnant women. What are these vaccines? How will they be licensed? What have we learned Read more…
Networking session in the Networking Lounge for PhD’s and early career researchers.
Parent Power Panel – Convener: Jane Plumb (30 mins) – 15.30 pm – 16.00 pm Parent voices must be at the heart of advocacy, policy-making and care relating to stopping group B Strep infection in babies – three parents share their experiences. S1: Charlotte Cleary S2: Kallie Hess S3: Debbie Read more…
Current state-of-art and what is next in Immunity, Seroepidemiology and Genomics applied to GBS surveillance and vaccine development. Senior and junior researchers from all over the world come together in parallel session 3 to discuss the present and future of immunity, seroepidemiology and genomics applied to GBS surveillance and vaccine development. The first Read more…
11.00 am – 11.30 am – Laboratory Now + Next – Professor Lakshmi Rajagopal Title: Role of GBS virulence factors in preterm births The presentation will feature our observations on how GBS uses either the proinflammatory hemolysin or the anti-inflammatory hyaluronidase to induce preterm labour during choriodecidual infections. 11.30 am Read more…
Please have a look at our poster booths, leave questions for the academics and vote on the best poster!
Group B Streptococcal disease remains a leading cause of sepsis and meningitis in young infants. In the ISSAD Epidemiology track, renowned speakers from across the globe showcase the long-term outcome data in GBS survivors from low/middle- and high-income countries. The track includes analysing multicentre, cross-cutting high-quality data estimates of neurodevelopmental Read more…